Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) had its price objective reduced by B. Riley from $4.00 to $3.00 in a research note released on Friday,Benzinga reports. They currently have ...

A new study finds that patients with systemic sclerosis (SSc) have a significantly higher risk of cancer-related mortality, ...

which is in Phase I clinical trial to treat non-small cell lung cancer. Receive News & Ratings for Lineage Cell Therapeutics Daily - Enter your email address below to receive a concise daily ...

Mar. 26, 2025 — Glucose is life's main energy source. But a new study reveals a surprising role as a master manipulator of tissue maturation, hinting at its importance in diabetes and ...

Mar. 18, 2025 — Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

Alterations in epigenetic programs, which include changes in DNA methylation and upregulation of EZH2, are now recognized to have a role in prostate cancer lineage plasticity. 2,3 It is felt that EZH2 ...

Netflix’s 2025 documentary ‘Con Mum’ follows pastry chef Graham Hornigold, who was scammed by a woman claiming to be his ...

In recognition of their significant achievements to advance cancer care and research, Lauren Byers, M.D., and Paul Scheet, Ph ...